| Gene symbol | CEACAM5 | Synonyms | CD66e, CEA | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Description | CEA cell adhesion molecule 5 | ||||
| GTO ID | GTC2051 |
| Trial ID | NCT03818165 |
| Disease | Pancreatic Carcinoma |
| Altered gene | CEA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR2 Anti-CEA CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases |
| Year | 2019 |
| Country | United States |
| Company sponsor | Sorrento Therapeutics, Inc. |
| Other ID(s) | SOR-CART-CEA-001 |
| Cohort 1 | |||||||
|
|||||||